GLP-1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes
João Sérgio Neves, Marta Borges‐Canha, Francisco Vasques‐Nóvoa, Jennifer B. Green, Lawrence A. Leiter, Christopher B. Granger, Davide Carvalho, Adelino Leite‐Moreira, Adrian F. Hernandez, Stefano Del Prato, John J.V. McMurray, João Pedro Ferreira
Topics & Concepts
MedicineType 2 diabetesAgonistPharmacologyGlucagon-like peptide 1 receptorDiabetes mellitusReceptorInternal medicineEndocrinologyDiabetes Treatment and ManagementPancreatic function and diabetesDiabetes Management and Research